ATG5 and cervical carcinoma: In summary, ATG5 involved in the EMT process and immune regulation in cervical cancer could affect the survival of cervical cancer patients by expression and methylation level, proposing that ATG5 may be a potentially powerful therapeutic target for cervical cancer (Figure 11).